DOI:
10.1055/s-00000133
Gastroenterologie up2date
LinksClose Window
References
Gedaly R, Angulo P, Hundley J et al.
PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation.
J Surg Res 2012;
176: 542-548
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.